PCSK9 and liver cancer: From the regulatory roles of PRDM1, S100A proteins, and PCSK9 to the implications of FoxO1 and CSF-1R, these results pave the way for novel therapeutic approaches aimed at modulating TAMs and enhancing immune responses in liver cancer.